NO981537L - FremgangsmÕte for fremstilling av antimalariamedikamenter - Google Patents
FremgangsmÕte for fremstilling av antimalariamedikamenterInfo
- Publication number
- NO981537L NO981537L NO981537A NO981537A NO981537L NO 981537 L NO981537 L NO 981537L NO 981537 A NO981537 A NO 981537A NO 981537 A NO981537 A NO 981537A NO 981537 L NO981537 L NO 981537L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- antimalarial drugs
- antimalarial
- drugs
- Prior art date
Links
- 239000003430 antimalarial agent Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/40—Nitrogen atoms attached in position 8
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9521004.3A GB9521004D0 (en) | 1995-10-13 | 1995-10-13 | Process |
| PCT/EP1996/004433 WO1997013753A1 (en) | 1995-10-13 | 1996-10-11 | Process for the preparation of anti-malarial drugs |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO981537D0 NO981537D0 (no) | 1998-04-03 |
| NO981537L true NO981537L (no) | 1998-04-03 |
| NO313285B1 NO313285B1 (no) | 2002-09-09 |
Family
ID=10782264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19981537A NO313285B1 (no) | 1995-10-13 | 1998-04-03 | Fremgangsmåte for fremstilling av forbindelser som er nyttige for antimalariamedikamenter, samt mellomprodukter forfremgangsmåten |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6479660B1 (no) |
| EP (1) | EP0871616B1 (no) |
| JP (1) | JP4083803B2 (no) |
| KR (1) | KR100453256B1 (no) |
| CN (1) | CN1147475C (no) |
| AR (1) | AR004015A1 (no) |
| AT (1) | ATE214372T1 (no) |
| AU (1) | AU709333B2 (no) |
| BR (1) | BR9611010A (no) |
| CA (1) | CA2231633C (no) |
| CZ (1) | CZ290380B6 (no) |
| DE (1) | DE69619863T2 (no) |
| DK (1) | DK0871616T3 (no) |
| ES (1) | ES2170874T3 (no) |
| GB (1) | GB9521004D0 (no) |
| HU (1) | HUP9900739A3 (no) |
| IL (1) | IL124060A (no) |
| NO (1) | NO313285B1 (no) |
| NZ (1) | NZ320209A (no) |
| PL (1) | PL186055B1 (no) |
| PT (1) | PT871616E (no) |
| SA (1) | SA97170574B1 (no) |
| SI (1) | SI0871616T1 (no) |
| TR (1) | TR199800637T2 (no) |
| TW (1) | TW450950B (no) |
| WO (1) | WO1997013753A1 (no) |
| ZA (1) | ZA968550B (no) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08276712A (ja) * | 1995-04-05 | 1996-10-22 | Masao Tsuji | チュ−ブレススパイクタイヤ |
| GB0210150D0 (en) * | 2002-05-03 | 2002-06-12 | Smithkline Beecham Plc | Process |
| PL1924558T3 (pl) * | 2005-09-12 | 2010-07-30 | Council Scient Ind Res | Przeciwmalaryczne addukty Baylisa Hillmana oraz proces ich wywarzania |
| WO2007127930A2 (en) * | 2006-04-28 | 2007-11-08 | Kansas State University Research Foundation | Compounds affecting gap junction activity |
| GB0620005D0 (en) | 2006-10-10 | 2006-11-22 | Glaxo Group Ltd | Compounds |
| US20090076072A1 (en) * | 2007-09-14 | 2009-03-19 | Protia, Llc | Deuterium-enriched tafenoquine |
| ES2453206B1 (es) | 2013-09-25 | 2015-01-12 | Thyssenkrupp Elevator Innovation Center, S.A. | Sistema de tracción para un sistema de transporte |
| CN113248431A (zh) * | 2021-05-21 | 2021-08-13 | 重庆医药高等专科学校 | 一种磷酸伯氨喹的制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4431807A (en) * | 1980-06-12 | 1984-02-14 | The United States Of America As Represented By The Secretary Of The Army | 4-Methyl-5-(unsubstituted and substituted phenoxy)-6-methoxy-8-(aminoalkylamino)quinolines |
| US4617394A (en) | 1985-10-15 | 1986-10-14 | The United States Of America As Represented By The Secretary Of The Army | 4-methyl-5-(unsubstituted and substituted phenoxy)-2,6-dimethoxy-8-(aminoalkylamino) quinolines |
-
1995
- 1995-10-13 GB GBGB9521004.3A patent/GB9521004D0/en active Pending
-
1996
- 1996-10-10 ZA ZA9608550A patent/ZA968550B/xx unknown
- 1996-10-11 BR BR9611010A patent/BR9611010A/pt not_active Application Discontinuation
- 1996-10-11 KR KR10-1998-0702696A patent/KR100453256B1/ko not_active Expired - Fee Related
- 1996-10-11 SI SI9630461T patent/SI0871616T1/xx unknown
- 1996-10-11 AT AT96934646T patent/ATE214372T1/de not_active IP Right Cessation
- 1996-10-11 IL IL12406096A patent/IL124060A/xx not_active IP Right Cessation
- 1996-10-11 PT PT96934646T patent/PT871616E/pt unknown
- 1996-10-11 NZ NZ320209A patent/NZ320209A/xx not_active IP Right Cessation
- 1996-10-11 DE DE69619863T patent/DE69619863T2/de not_active Expired - Lifetime
- 1996-10-11 DK DK96934646T patent/DK0871616T3/da active
- 1996-10-11 ES ES96934646T patent/ES2170874T3/es not_active Expired - Lifetime
- 1996-10-11 EP EP96934646A patent/EP0871616B1/en not_active Expired - Lifetime
- 1996-10-11 AR ARP960104723A patent/AR004015A1/es active IP Right Grant
- 1996-10-11 US US09/051,571 patent/US6479660B1/en not_active Expired - Fee Related
- 1996-10-11 CN CNB961975644A patent/CN1147475C/zh not_active Expired - Fee Related
- 1996-10-11 JP JP51471997A patent/JP4083803B2/ja not_active Expired - Fee Related
- 1996-10-11 AU AU72910/96A patent/AU709333B2/en not_active Ceased
- 1996-10-11 TR TR1998/00637T patent/TR199800637T2/xx unknown
- 1996-10-11 CZ CZ19981103A patent/CZ290380B6/cs not_active IP Right Cessation
- 1996-10-11 CA CA002231633A patent/CA2231633C/en not_active Expired - Fee Related
- 1996-10-11 PL PL96326194A patent/PL186055B1/pl not_active IP Right Cessation
- 1996-10-11 HU HU9900739A patent/HUP9900739A3/hu unknown
- 1996-10-11 WO PCT/EP1996/004433 patent/WO1997013753A1/en not_active Ceased
- 1996-10-14 TW TW085112489A patent/TW450950B/zh active
-
1997
- 1997-01-20 SA SA97170574A patent/SA97170574B1/ar unknown
-
1998
- 1998-04-03 NO NO19981537A patent/NO313285B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI973281L (fi) | Menetelmä tiettyjen atsasykloheksapeptidien valmistamiseksi | |
| NO974557D0 (no) | Fremgangsmåte for fremstilling av respirerbare partikler | |
| NO973938D0 (no) | Farmasöytisk preparat av piperdinoalkanolforbindelser | |
| NO961006L (no) | Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene | |
| NO981800L (no) | FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan | |
| NO944871L (no) | Fremgangsmåte for fremstilling av polydimetylsiloksaner | |
| TR199600857A2 (tr) | Nikotinamidin hazirlanmasi icin islem. | |
| NO982237L (no) | FremgangsmÕte for fremstilling av fenylimidazolidinderivater | |
| NO981537D0 (no) | Fremgangsmåte for fremstilling av antimalariamedikamenter | |
| FI964229A0 (fi) | Menetelmä doksorubisiinin valmistamiseksi | |
| NO955082L (no) | Fremgangsmåte for fremstilling av glutardialdehyd | |
| NO980384D0 (no) | Fremgangsmåte for fremstilling av fastdoseformer av svært lav-dose legemidler | |
| NO996432D0 (no) | Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider | |
| NO963432D0 (no) | Fremgangsmåte for fremstilling av dimetyldiklorsilan | |
| NO20003393L (no) | FremgangsmÕte for fremstilling av en farmasøytisk formulering | |
| NO981798D0 (no) | FremgangsmÕte for fremstilling av faste legemiddelformer | |
| NO973835D0 (no) | Fremgangsmåte for fremstilling av lorakarbefmonohydrat | |
| NO974747D0 (no) | Fremgangsmåte for fremstilling av streptograminer | |
| NO962809D0 (no) | Fremgangsmåte for fremstilling av N-substituerte 4-ketoprolinderivater | |
| NO964519D0 (no) | Fremgangsmåte for fremstilling av chitosanalkylderivater | |
| NO972129D0 (no) | Fremgangsmåte for fremstilling av 1-halo-3-trialkylsilanyl-benzenderivater | |
| NO20003077D0 (no) | FremgangsmÕte for fremstilling av klorbenzooksazolen | |
| NO994557D0 (no) | Fremgangsmaate for fremstilling av arylaminotriazolopyridiner | |
| NO961004L (no) | Fremgangsmåte for fremstilling av N-acetyl-D-glukosamin-deacetylase | |
| NO20002476L (no) | FremgangsmÕte for fremstilling av formylimidazoler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |